FWD 1 Commission E: Eucalyptus leaf

  The Commission E Monographs

Eucalyptus leaf


Eucalypti folium
Eucalyptusbltter
Published September 24, 1986; Revised March 13, 1990

Name of Drug

Eucalypti folium, eucalyptus leaf.  

Composition of Drug

Eucalyptus leaf consists of the dried, mature leaves from older trees of Eucalyptus globulus Labillardiere [Fam.  Myrtaceae], as well as other preparations in effective dosage.  

The leaves contain essential oil which consists mainly of 1,8-cineol and tannins.  

Uses

Catarrhs of the respiratory tract.  

Contraindications

Inflammation of the gastrointestinal tract and the bile ducts; serious liver diseases.  Eucalyptus preparations should not be applied to the face, especially the nose, of babies and very young children.  

Side Effects

In rare cases, after taking eucalyptus preparations nausea, vomiting, and diarrhea may occur.  

Interactions with Other Drugs

None known.  

Note:Eucalyptus oil induces the enzyme system of the liver involved in the detoxification process.  Therefore, the effects of other drugs can be weakened and/or shortened.

Dosage

Internal:
Average daily dosage:

  • 4 - 6 g of leaf;
  • equivalent preparations.  

Tincture (according to Erg.  B.  6 ):

  • Daily dosage 3 - 9 g.  

Mode of Administration

Chopped leaf for infusions and other galenical preparations for internal and external application.  

Actions

Secretomotory
Expectorant
Weakly antispasmodic